Welcome to
THABOR THERAPEUTICS

Changing the course of mucosal inflammatory diseases by reinstating mucosal homeostasis

About Us

Our approach is to target the first stress signal coming from the epithelium in the context of mucosal inflammatory disorders (MIDs). Doing so, we reinstate epithelial homeostasis by preventing inflammation, fibrosis and disruption of epithelial integrity. We also bring safety to patients as our approach is not immunosuppressive.

About Us

Our approach is to target the first stress signal coming from the epithelium in the context of mucosal inflammatory disorders (MIDs). Doing so, we reinstate epithelial homeostasis by preventing inflammation, fibrosis and disruption of epithelial integrity. We also bring safety to patients as our approach is not immunosuppressive.

THABOR

Our Team

The company is managed by a highly-experienced and complementary team, supported by a scientific team consisted by 3 scientific founders who are used to entrepreunarial experiences, and who conducted academic research (at INSERM and AP-HP) over the past decade to identify the new target.

Our Team

The company is managed by a highly-experienced and complementary team, supported by a scientific team consisted by 3 scientific founders who are used to entrepreunarial experiences, and who conducted academic research (at INSERM and AP-HP) over the past decade to identify the new target.

Scientific & Clinical Partners

Institutional & Funding Partners

Contact Us

Contact Us